The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

DIAC arbitration for an international engineering firm
Lead counsel to an international engineering firm providing engineering, design, planning, and construction services around the world, in a DIAC more
Security and privacy provisions for global logistics company
Revision of security and privacy provisions in a form of distribution agreement to be used globally by a global logistics provider. more
Power plant environmental permitting and compliance issues
Represent developer of new 500 MW natural gas-fired power plant in environmental permitting and compliance issues related to project development, more
Environmental coverage litigation for a major electrical equipment manufacturer
Represented a major electrical equipment manufacturer in environmental coverage litigation. more